“…In this sense, the measurement of plasmatic GSH would not reflect the real GSH status, once red blood cells represent 99.5% of the circulating GSH, being responsible for the erythrocyte homeostasis against oxidative damage. [25,42,43] All these aspects could be involved in the decrease of erythrocyte GSH levels and consequently high levels of MDA, in spite of NAC treatment.…”